GEBRO Holding and Spektus Pharma have established a global commercialisation partnership for ActraFlex, an extended-release pain management therapy taken twice daily. This collaboration may enhance the market presence of ActraFlex and improve access for patients in need of pain management solutions. The partnership could also provide GEBRO and Spektus with opportunities to leverage each other’s strengths in distribution and marketing, potentially leading to increased sales and market share.
Source: pharmaceutical-technology.com · Image: The Manufacturers Association held their presidential meeting on 10 July 1983 (FL45856571) by Dan Hadani, CC BY 4.0, via Wikimedia Commons
Use the database as your supply chain compass →